Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory Prostate Cancer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03315260
What this trial is testing

Treatment Satisfaction With Ra-223 in Japan

Who this might be right for
Prostatic Neoplasms
Bayer 85
Testing effectiveness (Phase 2)Ended earlyNCT03531827
What this trial is testing

Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment

Who this might be right for
Metastatic Castration Resistant Prostate CancerProstate Neoplasms
National Cancer Institute (NCI) 4
Early research (Phase 1)Looking for participantsNCT06067841
What this trial is testing

Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Bristol-Myers Squibb 140
Early research (Phase 1)Study completedNCT00644488
What this trial is testing

A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 7
Testing effectiveness (Phase 2)Looking for participantsNCT07363486
What this trial is testing

Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
First Affiliated Hospital of Fujian Medical University 9
Early research (Phase 1)Study completedNCT02833883
What this trial is testing

Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration Resistant Prostate Cancer
Memorial Sloan Kettering Cancer Center 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07802704
What this trial is testing

Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Neoplasms, Prostate
GlaxoSmithKline 684
Testing effectiveness (Phase 2)Study completedNCT01477749
What this trial is testing

Sipuleucel-T Manufacturing Demonstration Study

Who this might be right for
Cancer of ProstateCancer of the ProstateNeoplasms, Prostate+4 more
Dendreon 47
Early research (Phase 1)Ended earlyNCT00848601
What this trial is testing

Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma

Who this might be right for
Prostate CancerNon-Hodgkins Lymphoma
Astex Pharmaceuticals, Inc. 14
Early research (Phase 1)Study completedNCT01574937
What this trial is testing

XL-184+Abiraterone in Post-Chemo CRPC

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 27
Early research (Phase 1)Study completedNCT02625857
What this trial is testing

Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Janssen Research & Development, LLC 26
Early research (Phase 1)Looking for participantsNCT07493512
What this trial is testing

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Amgen 40
Testing effectiveness (Phase 2)Looking for participantsNCT07288359
What this trial is testing

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Who this might be right for
Advanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid TumorsMetastatic Castration-resistant Prostate Cancer
Novartis Pharmaceuticals 205
Testing effectiveness (Phase 2)Study completedNCT00020254
What this trial is testing

Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01017939
What this trial is testing

A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 34
Early research (Phase 1)Study completedNCT02730975
What this trial is testing

Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 42
Early research (Phase 1)Looking for participantsNCT06879041
What this trial is testing

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
AstraZeneca 136
Large-scale testing (Phase 3)Looking for participantsNCT07164443
What this trial is testing

Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostatic Neoplasms
Janssen Research & Development, LLC 1,203
Testing effectiveness (Phase 2)Study completedNCT01576172
What this trial is testing

Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer AJCC v7
National Cancer Institute (NCI) 159
Not applicableEnded earlyNCT01076751
What this trial is testing

Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

Who this might be right for
Prostatic Neoplasms
Sanofi 82
Next Page